Peptide for blocking autoantibody-evoked activation of glutamate receptor type 3 (GLUR3)
US5731410A · kind A · utility
1Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 28, 1994 |
| Grant date | Mar 24, 1998 |
| Priority date | — |
| Expiry date | Nov 28, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/811
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A peptide containing 24 amino acid residues that binds to anti-neuronal-glutamate-receptor autoantibodies associated with Rasmussen's encephalitis and that blocks activation of the GluR3 subunit is described. Methods of making the peptide and treating Rasmussen's encephalitis are also disclosed. Autoantibodies to other glutamate receptor subunits are associated with paraneoplastic neurodegenerative disease, amyotrophic lateral sclerosis, and neurodegenerative disease of unknown diagnosis. Methods of screening patients and of monitoring patients being treated for these disorders and syndromes are further described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.